REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 216 filers reported holding REVANCE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodline Partners LP | 107,580 | $2,722,850 | 0.03% |
| Aquatic Capital Management LLC | 23,100 | $585 | 0.03% |
| Centiva Capital, LP | 50,000 | $1,265,500 | 0.03% |
| West Tower Group, LLC | 1,548 | $39,180 | 0.03% |
| ALLIANCEBERNSTEIN L.P. | 2,596,263 | $65,711,417 | 0.03% |
| FRANKLIN RESOURCES INC | 2,262,479 | $57,263,344 | 0.03% |
| DAYMARK WEALTH PARTNERS, LLC | 14,000 | $354,340 | 0.03% |
| M&G INVESTMENT MANAGEMENT LTD | 246,098 | $6,152,450 | 0.02% |
| PROFUND ADVISORS LLC | 18,606 | $470,918 | 0.02% |
| Point72 Middle East FZE | 33,740 | $853,959 | 0.02% |
| Virtu Financial LLC | 12,589 | $319 | 0.02% |
| Graham Capital Management, L.P. | 32,297 | $817,437 | 0.02% |
| MOORE CAPITAL MANAGEMENT, LP | 55,000 | $1,392,050 | 0.02% |
| CIBC Asset Management Inc | 233,006 | $5,897,382 | 0.02% |
| Accredited Investors Inc. | 12,845 | $325,107 | 0.02% |
| Centiva Capital, LP | 40,000 | $1,012,400 | 0.02% |
| Perfromance Wealth Partners, LLC | 18,500 | $457,320 | 0.02% |
| GILDER GAGNON HOWE & CO LLC | 57,123 | $1,445,783 | 0.02% |
| Caption Management, LLC | 40,200 | $1,017,462 | 0.02% |
| Yarbrough Capital, LLC | 12,203 | $308,858 | 0.02% |
External links
This page lists REVANCE THERAPEUTICS INC's shareholders in Q2 2023. To view REVANCE THERAPEUTICS INC's shareholder history, click here.